DividendInvestor.com

First In Dividend Data Worldwide®

DIVIDEND ANNOUNCEMENT: Merrimack Pharmaceuticals Inc (NASDAQ:MACK) on 12/03/2019 declared a dividend of $0.5000 per share

December 03, 2019

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) on 12/03/2019 declared a dividend of $ 0.5000 per share payable on December 23, 2019 to shareholders of record as of December 16, 2019. Dividend amount recorded is a decrease of $ 0.9967 from last dividend Paid.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has paid dividends since 2017, has a current dividend yield of 13.3333330154% and has increased its dividends for 0 successive years.

Merrimack Pharmaceuticals Inc's market cap is $ 50,111,250 and has a PE ratio of 0.00. The stock price closed yesterday at $ 3.75 and has a 52 week low/high of $ 3.51 and $ 7.50.

Merrimack Pharmaceuticals is a clinical stage biopharmaceutical company that is targeting biomarker-defined cancers. Co.'s clinical stage asset in active development is MM-310. MM-310 is an antibody-directed nanotherapeutic that targets the ephrin receptor A2, (EphA2), receptor and contains a cytotoxic taxane. The EphA2 receptor is expressed in most solid tumor types, such as prostate, ovarian, bladder, gastric, pancreatic and lung cancers. Co.'s two preclinical programs are MM-401, an agonistic antibody targeting an immuno-oncology target, TNFR2, and MM-201, a stabilized agonist-Fc fusion protein targeting death receptors 4 and 5.

For more information on Merrimack Pharmaceuticals Inc click here.

Merrimack Pharmaceuticals Inc current dividend information as per the date of this press release is:
Dividend Declaration Date: December 03, 2019
Dividend Ex Date: December 13, 2019
Dividend Record Date: December 16, 2019
Dividend Payment Date: December 23, 2019
Dividend Amount: $ 0.5000
 
 

DividendInvestor.com

DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.

Contact:
info@DividendInvestor.com

X
Search Dividend Investor